J Gynecol Oncol.  2008 Dec;19(4):207-208. 10.3802/jgo.2008.19.4.207.

Should we modify the current FIGO staging system for stage IIIC ovarian cancer?

• Ryu HS

• KMID: 2173407
• DOI: http://doi.org/10.3802/jgo.2008.19.4.207

Abstract

No abstract available.

Reference

1. Choi M, Fuller CD, Thomas CR Jr, Wang SJ. Conditional survival in ovarian cancer: Results from the SEER dataset 1988-2001. Gynecol Oncol. 2008. 109:203–209.

2. Korea Central Cancer Registry, Ministry of Health and Welfare. 2002 Annual report of the Korea central cancer. 2003. Seoul: Ministry of Health and Welfare.

3. Chen SS, Lee L. Incidence of para-aortic and pelvic lymph node metastases in epithelial carcinoma of the ovary. Gynecol Oncol. 1983. 16:95–100.

4. Buchsbaum HJ, Brady MF, Delgado G, Miller A, Hoskins WJ, Manetta A, et al. Surgical staging of carcinoma of the ovaries. Surg Gynecol Obstet. 1989. 169:226–232.

5. FIGO Cancer Committee. Staging announcement. Gynecol Oncol. 1986. 25:383–385.

6. Chen SS. Survival of ovarian carcinoma with or without lymph node metastasis. Gynecol Oncol. 1987. 27:368–372.

7. Carnino F, Fuda G, Ciccone G, Iskra L, Guercio E, Dadone D, et al. Significance of lymph node sampling in epithelial carcinoma of the ovary. Gynecol Oncol. 1997. 65:467–472.

8. Onda T, Yoshikawa H, Yasugi T, Mishima M, Nakagawa S, Yamada M, et al. Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenectomy have similar survival to Stage I/II patients and superior survival to other Stage III patients. Cancer. 1998. 83:1555–1560.

9. Baek SJ, Park JY, Kim DY, Kim JH, Kim YM, Kim YT, et al. Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer. J Gynecol Oncol. 2008. 19:223–228.